Inherited Cancer Genetic Testing

The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, has awarded a contract for "Inherited Cancer Genetic Testing" to Informed Genetics. This contract is an essential procurement in the healthcare industry, specifically focusing on medical analysis services for hereditary cancer syndromes across NHS Wales. The award process involved a direct procurement method, ensuring that the services provided comply with clinical governance and align with national genomic standards.

The procurement process has been marked as complete, with the contract commencing on 1st January 2026 and concluding on 31st December 2026. Both parties are based in Cardiff, United Kingdom, with the supply services being delivered to the region of UKL22. This contract provides excellent opportunities for businesses specialising in healthcare and genetic testing services, particularly those with existing capabilities in medical analysis.

Companies that can demonstrate a strong track record in consistent, high-quality service delivery, and those with an understanding of the NHS Wales operations, may find potential collaboration opportunities in the future. The focus on strategic partnerships and direct procurement processes also opens avenues for businesses that excel in forming long-term relationships with public sector organisations to maintain operational continuity and efficiency. The healthcare sector demands high standards and specialisation, making this an ideal opportunity for large-scale providers with a commitment to clinical excellence.